▶ 調査レポート

抗癌剤の世界市場2018

• 英文タイトル:Global Anticancer Drugs Sales Market Report 2018

QYResearchが調査・発行した産業分析レポートです。抗癌剤の世界市場2018 / Global Anticancer Drugs Sales Market Report 2018 / D107790資料のイメージです。• レポートコード:D107790
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥424,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥848,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗癌剤の世界市場について調査・分析し、抗癌剤のメーカー別販売量、市場シェア分析、種類別販売分析(細胞傷害性薬物(アルキル化剤・代謝拮抗物質)、標的薬物(モノクローナル抗体およびチロシンキナーゼ阻害剤)、ホルモン薬)、用途別販売分析(肺癌、乳がん、白血病、結腸直腸癌)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、抗癌剤産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・抗癌剤市場概要
・抗癌剤のメーカー別販売量・メーカー別シェア
・抗癌剤の世界市場:種類別販売量(細胞傷害性薬物(アルキル化剤・代謝拮抗物質)、標的薬物(モノクローナル抗体およびチロシンキナーゼ阻害剤)、ホルモン薬)
・抗癌剤の世界市場:用途別販売量(肺癌、乳がん、白血病、結腸直腸癌)
・抗癌剤の世界市場:地域別販売量・市場シェア
・抗癌剤の米国市場規模
・抗癌剤の中国市場規模
・抗癌剤の欧州市場規模
・抗癌剤の日本市場規模
・抗癌剤の東南アジア市場規模
・抗癌剤のインド市場規模
・抗癌剤のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・抗癌剤のコスト分析・価格動向
・抗癌剤の産業チェーン(サプライチェーン分析)
・抗癌剤のマーケティング戦略・販売チャネル、流通業者
・抗癌剤市場への影響要因分析
・抗癌剤の世界市場予測
・抗癌剤の米国市場予測
・抗癌剤の中国市場予測
・抗癌剤の欧州市場予測
・抗癌剤の日本市場予測
・抗癌剤の東南アジア市場予測
・抗癌剤のインド市場予測
・抗癌剤の種類別世界市場予測(細胞傷害性薬物(アルキル化剤・代謝拮抗物質)、標的薬物(モノクローナル抗体およびチロシンキナーゼ阻害剤)、ホルモン薬)
・抗癌剤の用途別世界市場予測(肺癌、乳がん、白血病、結腸直腸癌)
...

This report studies the global Anticancer Drugs market status and forecast, categorizes the global Anticancer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
At present, there are more than 80 kinds of anti-cancer drugs commonly used in clinical practice in the world, which can be roughly divided into the following 6 categories: cytotoxic drugs, hormone drugs, biological response modifiers, monoclonal antibody drugs, other drugs, and auxiliary drugs.
The global Anticancer Drugs market is valued at 89300 million US$ in 2017 and will reach 163400 million US$ by the end of 2025, growing at a CAGR of 7.9% during 2018-2025.

The major players covered in this report
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer

The study objectives of this report are:
To analyze and study the global Anticancer Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Anticancer Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anticancer Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anticancer Drugs Manufacturers
Anticancer Drugs Distributors/Traders/Wholesalers
Anticancer Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anticancer Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Anticancer Drugs Sales Market Report 2018
1 Anticancer Drugs Market Overview
1.1 Product Overview and Scope of Anticancer Drugs
1.2 Classification of Anticancer Drugs by Product Category
1.2.1 Global Anticancer Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Anticancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.4 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.5 Hormonal Drugs
1.3 Global Anticancer Drugs Market by Application/End Users
1.3.1 Global Anticancer Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Lung Cancer
1.3.2 Breast Cancer
1.3.3 Leukemia
1.3.4 Colorectal Cancer
1.4 Global Anticancer Drugs Market by Region
1.4.1 Global Anticancer Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Anticancer Drugs Status and Prospect (2013-2025)
1.4.3 Europe Anticancer Drugs Status and Prospect (2013-2025)
1.4.4 China Anticancer Drugs Status and Prospect (2013-2025)
1.4.5 Japan Anticancer Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Anticancer Drugs Status and Prospect (2013-2025)
1.4.7 India Anticancer Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Anticancer Drugs (2013-2025)
1.5.1 Global Anticancer Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Anticancer Drugs Revenue and Growth Rate (2013-2025)

2 Global Anticancer Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Anticancer Drugs Market Competition by Players/Suppliers
2.1.1 Global Anticancer Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Anticancer Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Anticancer Drugs (Volume and Value) by Type
2.2.1 Global Anticancer Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Anticancer Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Anticancer Drugs (Volume and Value) by Region
2.3.1 Global Anticancer Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Anticancer Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Anticancer Drugs (Volume) by Application

3 United States Anticancer Drugs (Volume, Value and Sales Price)
3.1 United States Anticancer Drugs Sales and Value (2013-2018)
3.1.1 United States Anticancer Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Anticancer Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Anticancer Drugs Sales Price Trend (2013-2018)
3.2 United States Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Anticancer Drugs (Volume, Value and Sales Price)
4.1 Europe Anticancer Drugs Sales and Value (2013-2018)
4.1.1 Europe Anticancer Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Anticancer Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Anticancer Drugs Sales Price Trend (2013-2018)
4.2 Europe Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Anticancer Drugs (Volume, Value and Sales Price)
5.1 China Anticancer Drugs Sales and Value (2013-2018)
5.1.1 China Anticancer Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Anticancer Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Anticancer Drugs Sales Price Trend (2013-2018)
5.2 China Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Anticancer Drugs (Volume, Value and Sales Price)
6.1 Japan Anticancer Drugs Sales and Value (2013-2018)
6.1.1 Japan Anticancer Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Anticancer Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Anticancer Drugs Sales Price Trend (2013-2018)
6.2 Japan Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Anticancer Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Anticancer Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Anticancer Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Anticancer Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Anticancer Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Anticancer Drugs (Volume, Value and Sales Price)
8.1 India Anticancer Drugs Sales and Value (2013-2018)
8.1.1 India Anticancer Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Anticancer Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Anticancer Drugs Sales Price Trend (2013-2018)
8.2 India Anticancer Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Anticancer Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Anticancer Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Anticancer Drugs Players/Suppliers Profiles and Sales Data
9.1 F. Hoffmann-La Roche Ltd
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Anticancer Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly and Company
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Anticancer Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 CELGENE CORPORATION
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Anticancer Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Novartis AG
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Anticancer Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Novartis AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Pfizer Inc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Anticancer Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Amgen Inc
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Anticancer Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Amgen Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Bayer AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Anticancer Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bayer AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 AstraZeneca
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Anticancer Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 AstraZeneca Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Anticancer Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Merck & Co.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Anticancer Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Anticancer Drugs Maufacturing Cost Analysis
10.1 Anticancer Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Anticancer Drugs
10.3 Manufacturing Process Analysis of Anticancer Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Anticancer Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anticancer Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Anticancer Drugs Market Forecast (2018-2025)
14.1 Global Anticancer Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Anticancer Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Anticancer Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Anticancer Drugs Price and Trend Forecast (2018-2025)
14.2 Global Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Anticancer Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Anticancer Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Anticancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Anticancer Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Anticancer Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Anticancer Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Anticancer Drugs Price Forecast by Type (2018-2025)
14.4 Global Anticancer Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Anticancer Drugs
Figure Global Anticancer Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Anticancer Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Product Picture
Figure Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Product Picture
Figure Hormonal Drugs Product Picture
Figure Global Anticancer Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Anticancer Drugs by Application in 2017
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Leukemia Examples
Table Key Downstream Customer in Leukemia
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Global Anticancer Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anticancer Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Anticancer Drugs Sales Volume (K Units) (2013-2018)
Table Global Anticancer Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Anticancer Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Anticancer Drugs Sales Share by Players/Suppliers
Figure 2017 Anticancer Drugs Sales Share by Players/Suppliers
Figure Global Anticancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anticancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anticancer Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Anticancer Drugs Revenue Share by Players
Table 2017 Global Anticancer Drugs Revenue Share by Players
Table Global Anticancer Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Anticancer Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Anticancer Drugs by Type (2013-2018)
Figure Global Anticancer Drugs Sales Growth Rate by Type (2013-2018)
Table Global Anticancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Anticancer Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anticancer Drugs by Type (2013-2018)
Figure Global Anticancer Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Anticancer Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Anticancer Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Anticancer Drugs by Region (2013-2018)
Figure Global Anticancer Drugs Sales Growth Rate by Region in 2017
Table Global Anticancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anticancer Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anticancer Drugs by Region (2013-2018)
Figure Global Anticancer Drugs Revenue Growth Rate by Region in 2017
Table Global Anticancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anticancer Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anticancer Drugs by Region (2013-2018)
Figure Global Anticancer Drugs Revenue Market Share by Region in 2017
Table Global Anticancer Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Anticancer Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Anticancer Drugs by Application (2013-2018)
Figure Global Anticancer Drugs Sales Market Share by Application (2013-2018)
Figure United States Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Anticancer Drugs Sales Volume Market Share by Players in 2017
Table United States Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Anticancer Drugs Sales Volume Market Share by Type in 2017
Table United States Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Anticancer Drugs Sales Volume Market Share by Application in 2017
Figure Europe Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Anticancer Drugs Sales Volume Market Share by Players in 2017
Table Europe Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Anticancer Drugs Sales Volume Market Share by Type in 2017
Table Europe Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Anticancer Drugs Sales Volume Market Share by Application in 2017
Figure China Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Anticancer Drugs Sales Volume Market Share by Players in 2017
Table China Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Anticancer Drugs Sales Volume Market Share by Type in 2017
Table China Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Anticancer Drugs Sales Volume Market Share by Application in 2017
Figure Japan Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Anticancer Drugs Sales Volume Market Share by Players in 2017
Table Japan Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Anticancer Drugs Sales Volume Market Share by Type in 2017
Table Japan Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Anticancer Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Anticancer Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Anticancer Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Anticancer Drugs Sales Volume Market Share by Application in 2017
Figure India Anticancer Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Anticancer Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Anticancer Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Anticancer Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Anticancer Drugs Sales Volume Market Share by Players in 2017
Table India Anticancer Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Anticancer Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Anticancer Drugs Sales Volume Market Share by Type in 2017
Table India Anticancer Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Anticancer Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Anticancer Drugs Sales Volume Market Share by Application in 2017
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Sales Global Market Share (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Revenue Global Market Share (2013-2018)
Table CELGENE CORPORATION Basic Information List
Table CELGENE CORPORATION Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CELGENE CORPORATION Anticancer Drugs Sales Growth Rate (2013-2018)
Figure CELGENE CORPORATION Anticancer Drugs Sales Global Market Share (2013-2018
Figure CELGENE CORPORATION Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Novartis AG Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Novartis AG Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Inc Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Inc Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Pfizer Inc Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Amgen Inc Basic Information List
Table Amgen Inc Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Inc Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Amgen Inc Anticancer Drugs Sales Global Market Share (2013-2018
Figure Amgen Inc Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Bayer AG Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Bayer AG Anticancer Drugs Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Anticancer Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Anticancer Drugs Sales Global Market Share (2013-2018
Figure AstraZeneca Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Anticancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co. Anticancer Drugs Sales Global Market Share (2013-2018)
Figure Merck & Co. Anticancer Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticancer Drugs
Figure Manufacturing Process Analysis of Anticancer Drugs
Figure Anticancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anticancer Drugs Major Players in 2017
Table Major Buyers of Anticancer Drugs
Table Distributors/Traders List
Figure Global Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anticancer Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Anticancer Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Anticancer Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Anticancer Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Anticancer Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Anticancer Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Anticancer Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Anticancer Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Anticancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Anticancer Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Anticancer Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Anticancer Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anticancer Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Anticancer Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Anticancer Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Anticancer Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources